Company Filing History:
2 out of 76 
1 out of 445 
1 out of 5 Years Active: 2006-2025
Title: The Innovative Contributions of Clifford Reid
Introduction
Clifford Reid, an accomplished inventor based in Pacifica, CA, has made significant contributions to the fields of cancer therapy and genomic research. With a portfolio of four patents, his work has begun to re-shape how we approach cancer treatment and genetic sequencing.
Latest Patents
Among Clifford Reid’s latest innovations is a patent focused on identifying cancer therapies. This invention employs in silico tools to determine potential effective treatments for patients based on a combination of patient, drug, and cancer data. By utilizing functional assays on live cancer cells, this method evaluates therapies and provides critical genomic data from a single sample. Additionally, machine learning is used to analyze correlations between patient profiles, cancer types, and drug efficacies, paving the way for personalized medicine.
Another notable patent covers efficient shotgun sequencing methods. This technique allows for the streamlined selection and sequencing of targeted nucleic acids from a genomic library. This innovation is particularly beneficial for capturing missing or uncertain genome sequences, ultimately enhancing the sequencing outcome with less redundancy and effort compared to traditional procedures.
Career Highlights
Clifford Reid has a distinguished career, including pivotal roles at Complete Genomics, Inc. and Open Text Corporation. His work in these companies has contributed significantly to advancements in genomics and cancer research. Reid’s innovative approach to problems has enabled him to develop tools that improve cancer treatment methods and genetic research.
Collaborations
Throughout his career, Reid has collaborated with notable professionals in the scientific community, including Radoje Drmanac and Murray K Low. These partnerships have played a key role in the development and refinement of his patents, showcasing the synergistic effect of teamwork in innovation.
Conclusion
Clifford Reid exemplifies the spirit of innovation in the medical and genetic research landscapes. With his impressive repertoire of patents and meaningful collaborations, his contributions are setting new standards in identifying effective cancer therapies and enhancing the efficiency of genomic sequencing. As he continues to push the boundaries of these fields, his work remains crucial for future advancements in healthcare.